JPRN-jRCTc030200089
Suspended
Phase 1
A clinical study on the immunological effect of the preventive immune-cell therapy (abT) against high risk group of cancer
Takimoto Rishu0 sites20 target enrollmentAugust 20, 2020
Overview
- Phase
- Phase 1
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Takimoto Rishu
- Enrollment
- 20
- Status
- Suspended
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •(1\)Have risk factors for cancer and desire for receiving the preemptive immune\-cell therapy.
- •(2\)Be \> 20 of age when obtaining the informed consent.
- •(3\)Be determined to be appropriate by the doctor in charge.
- •(4\)Provide written informed consent.
Exclusion Criteria
- •(1\)Be diagnosed with cancer.
- •(2\)Desire to receive the immune\-cell therapy for the treatment of any allergic disease.
- •(3\)Be HIV or HTLV\-1 positive.
- •(4\)Be an allotransplant recipient.
- •(5\)Have a history or sign of interstitial pneumonia.
- •(6\)Have an active autoimmune disease.
- •(7\)Be a female who is pregnant, nursing, or of childbearing potential.
- •(8\)A subject 70 years of age and above must be carefully considered for the risk of an autoimmune disease to enroll in this study.
- •(9\)Be determined to be inappropriate by the doctor in charge.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Suspended
Phase 1
Evaluation of immunological parameters in high risk group of cancer treated with immune-cell therapyJPRN-jRCTc030200090Takimoto Rishu20
Suspended
Phase 1
Evaluation of immunological parameters in high risk group of cancer treated with immune-cell therapynoneJPRN-jRCTc030200091Takimoto Rishu20
Recruiting
Phase 2
AcGM3/VSSP/Montanide ISA 51 formulation in HIV, phase II.Sexually Transmitted DiseasesHIV/AIDSHIV InfectionsLentivirus InfectionsRetroviridae InfectionsImmunologic Deficiency SyndromesSexually Transmitted Diseases, ViralImmune System DiseasesRPCEC00000015Center of Molecular Immunology(CIM)118
Not yet recruiting
Phase 2
Clinical Study on the immune Enhancing Effect of Nidigdhikadi Leha on Upper Respiratory Tract Infections (URTI)Health Condition 1: J399- Disease of upper respiratory tract, unspecifiedCTRI/2020/08/027386ational Institute of Ayurveda Jaipur
Completed
Phase 2
To study the effect of Swarnaprashan in reducing the frequency of illness in children by improving the immunity and increasing the body strength.CTRI/2021/05/033713ational Institute of Ayurveda Jaipur Rajasthan30